# Correction: Highly potent and selective phosphatidylinositol 4-kinase IIIβ inhibitors as broad-spectrum anti-rhinoviral agents

## TL;DR

This paper corrects a previously published study on new inhibitors that target a specific enzyme to fight rhinoviruses.

## Contribution

The correction addresses errors in the original study on anti-rhinoviral agents targeting phosphatidylinositol 4-kinase IIIβ.

## Key findings

- The correction clarifies data or methodology in the original paper on enzyme inhibitors.
- It ensures accuracy in the reported results of anti-rhinoviral agents.

## Abstract

Correction for ‘Highly potent and selective phosphatidylinositol 4-kinase IIIβ inhibitors as broad-spectrum anti-rhinoviral agents’ by Avinash G. Vishakantegowda et al., RSC Med. Chem., 2024, 15, 704–719, https://doi.org/10.1039/D3MD00630A.